From: Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Age, years (mean ± SD) | 62.9 ± 11.9 |
Men/women | 8/6 |
Duration of diabetes (months, mean ± SD) | 10.2 ± 7.6 |
DR scale (eyes) | NPDR 14 |
PDR 4 | |
Hemoglobin A1c (%) | 6.8 ± 0.5 |
History of photocoagulation (eyes) | 14 (57%) |
History of cataract surgery (eyes) | 6 (33%) |
VA (logMAR, mean ± SD) | 0.41 ± 0.24 |
Baseline FT (microns, mean ± SD) | 452 ± 77 |